Authors:
MORIMURA H
FISHMAN GA
GROVER SA
FULTON AB
BERSON EL
DRYJA TP
Citation: H. Morimura et al., MUTATIONS IN THE RPE65 GENE IN PATIENTS WITH AUTOSOMAL RECESSIVE RETINITIS-PIGMENTOSA OR LEBER CONGENITAL AMAUROSIS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(6), 1998, pp. 3088-3093
Authors:
GROVER SA
PAQUET S
LEVINTON C
COUPAL L
ZOWALL H
Citation: Sa. Grover et al., ESTIMATING THE BENEFITS OF MODIFYING RISK-FACTORS OF CARDIOVASCULAR-DISEASE - A COMPARISON OF PRIMARY VS SECONDARY PREVENTION, Archives of internal medicine, 158(6), 1998, pp. 655-662
Authors:
PERREAULT S
HAMILTON VH
LAVOIE F
GROVER SA
Citation: S. Perreault et al., TREATING HYPERLIPIDEMIA FOR THE PRIMARY PREVENTION OF CORONARY-DISEASE - ARE HIGHER DOSAGES OF LOVASTATIN COST-EFFECTIVE, Archives of internal medicine, 158(4), 1998, pp. 375-381
Authors:
GROVER SA
PAQUET S
LEVINTON C
COUPAL L
ZOWALL H
Citation: Sa. Grover et al., ESTIMATING THE BENEFITS OF MODIFYING RISK-FACTORS OF CARDIOVASCULAR-DISEASE - A COMPARISON OF PRIMARY VS SECONDARY PREVENTION (VOL 158, PG 655, 1998), Archives of internal medicine, 158(11), 1998, pp. 1228-1228
Authors:
CLARKE AE
ZOWALL H
LEVINTON C
ASSIMAKOPOULOS H
SIBLEY JT
HAGA M
SHIROKY J
NEVILLE C
LUBECK DP
GROVER SA
ESDAILE JM
Citation: Ae. Clarke et al., DIRECT AND INDIRECT MEDICAL COSTS INCURRED BY CANADIAN PATIENTS WITH RHEUMATOID-ARTHRITIS - A 12 YEAR STUDY, Journal of rheumatology, 24(6), 1997, pp. 1051-1060
Citation: M. Abrahamowicz et al., FLEXIBLE MODELING OF THE EFFECTS OF SERUM-CHOLESTEROL ON CORONARY HEART-DISEASE MORTALITY, American journal of epidemiology, 145(8), 1997, pp. 714-729
Citation: Kl. Esrey et al., RELATIONSHIP BETWEEN DIETARY-INTAKE AND CORONARY HEART-DISEASE MORTALITY - LIPID RESEARCH CLINICS PREVALENCE FOLLOW-UP-STUDY, Journal of clinical epidemiology, 49(2), 1996, pp. 211-216
Citation: Mg. Burnett et Sa. Grover, USE OF THE EMERGENCY DEPARTMENT FOR NONURGENT CARE DURING REGULAR BUSINESS HOURS, CMAJ. Canadian Medical Association journal, 154(9), 1996, pp. 1345-1351
Citation: L. Goldman et al., TASK-FORCE 6 - COST-EFFECTIVENESS OF ASSESSMENT AND MANAGEMENT OF RISK-FACTORS, Journal of the American College of Cardiology, 27(5), 1996, pp. 1020-1030
Authors:
CLARKE AE
ZOWALL H
LEVINTON C
ASSIMAKOPOULOS H
SIBLEY J
HAGA M
SHIROKY J
NEVILLE C
LUBECK DP
GROVER SA
ESDAILE JM
Citation: Ae. Clarke et al., THE MEDICAL COSTS INCURRED BY PATIENTS WITH RHEUMATOID-ARTHRITIS - A 12 YEAR STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 271-271
Authors:
MCLEOD PJ
MEAGHER T
CASSIDY L
WILLIAMS JI
GROVER SA
Citation: Pj. Mcleod et al., NON-URGENT EMERGENCY DEPARTMENT VISITS BY PATIENTS FROM A RESIDENT AMBULATORY CARE CLINIC, Academic medicine, 70(10), 1995, pp. 932-932
Authors:
GROVER SA
LOWENSTEYN I
ESREY KL
STEINERT Y
JOSEPH L
ABRAHAMOWICZ M
Citation: Sa. Grover et al., DO DOCTORS ACCURATELY ASSESS CORONARY RISK IN THEIR PATIENTS - PRELIMINARY-RESULTS OF THE CORONARY HEALTH ASSESSMENT STUDY, BMJ. British medical journal, 310(6985), 1995, pp. 975-978
Citation: Sa. Grover et al., IDENTIFYING ADULTS AT INCREASED RISK OF CORONARY-DISEASE - HOW WELL DO THE CURRENT CHOLESTEROL GUIDELINES WORK, JAMA, the journal of the American Medical Association, 274(10), 1995, pp. 801-806
Authors:
HAMILTON VH
RACICOT FE
ZOWALL H
COUPAL L
GROVER SA
Citation: Vh. Hamilton et al., THE COST-EFFECTIVENESS OF HMG-COA REDUCTASE INHIBITORS TO PREVENT CORONARY HEART-DISEASE - ESTIMATING THE BENEFITS OF INCREASING HDL-C, JAMA, the journal of the American Medical Association, 273(13), 1995, pp. 1032-1038
Authors:
WHITE PD
GROVER SA
KANGRO HO
THOMAS JM
AMESS J
CLARE AW
Citation: Pd. White et al., THE VALIDITY AND RELIABILITY OF THE FATIGUE SYNDROME THAT FOLLOWS GLANDULAR FEVER, Psychological medicine, 25(5), 1995, pp. 917-924
Authors:
GROVER SA
GRAYDONALD K
JOSEPH L
ABRAHAMOWICZ M
COUPAL L
Citation: Sa. Grover et al., CALCULATING GAINS IN LIFE EXPECTANCY WITH RISK FACTOR REDUCTION - REPLY, Archives of internal medicine, 155(12), 1995, pp. 1330-1332
Citation: Sa. Grover, LIFE EXPECTANCY FOLLOWING DIETARY MODIFICATION OR SMOKING CESSATION -ESTIMATING THE BENEFITS OF A PRUDENT LIFE-STYLE (VOL 154, PG 1697, 1994), Archives of internal medicine, 155(1), 1995, pp. 61-61
Citation: Sa. Grover et L. Coupal, RISK-BENEFIT ASSESSMENT OF DRUG-TREATMENT TO PREVENT CORONARY HEART-DISEASE - ESTIMATING THE BENEFITS OF RISK FACTOR MODIFICATION, Drug safety, 10(4), 1994, pp. 301-309